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Introduction
Fundamental research clearly shows that the product of the c-myc oncogene is often expressed at elevated levels in a large number of breast cancers and is associated with poor prognosis, high-risk disease (for further detail, see our recent review (3). Indeed, Myc drives cell proliferation and can initiate as well as contribute to tumor development, as confirmed by both in vitro and in vivo models of breast cancer. The highly conserved regions of the Myc protein are thought to participate in protein:protein interactions. Importantly, blocking these sites can effectively inhibit Myc function and block breast carcinoma cell growth. Thus, Myc is a valid target for the development of novel therapeutics to inhibit mammary cells of malignant transformations in a specific and sensitive manner. This is the primary goal of this proposal.
To achieve our goal, we are using the novel Repressed Transactivator (RTA) assay developed in collaboration with our lab (1) . The RTA is an in vivo functional assay that will enable Myc-binding proteins and inhibitors of Myc:protein interactions to be identified and characterized. This experimental tool is conceptually similar to the conventional "two-hybrid" technology but offers significant improvement. First, the RTA allows transactivator bait proteins like Myc, to be used in a two-hybrid approach to clone novel interactors. Second, the ability of the RTA to identify inhibitors of a given protein:protein interaction makes it particularly well suited for high throughput screening of protein:protein interactions and the identification of inhibitor compounds.
Objective/hypothesis
Our hypothesis is that Myc is a valid target for the development of novel therapeutics aimed at blocking essential Myc:protein complexes that drive the carcinogenic process of mammary epithelial cells.
Specific Aims
a. We will use the RTA to identify the Myc-binding domain of a recently identified Mycinteractor, TRRAP (2), and delineate the nature of a "Myc-signature sequence" with which other Myc-binding proteins can be identified by sequence databank analysis. b. Clone and characterize novel Myc-binding protein using the RTA to screen for MycNTD interactors in cells derived from human breast carcinomas. c. With these experimental tools in hand we will then use the RTA to identify specific inhibitors of these protein:protein interactions that will block Myc function and inhibit tumor cell proliferation.
Body
With support from the DOD, the research outlined in the original proposal has progressed in a steady and productive manner. To delineate the accomplishments, each task outlined in the Statement of Work is itemized below. The results of each task is summarized and the annual report in which the work the work was presented is provided. Statement of Work Task 1. To identify the Myc binding domain of TRRAP, a novel MycNTD-binding protein recently identified biochemically (months [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] a. Completed, 2002 . Overlapping fragments of TRRAP were cloned into the pBD prey vector using a PCR based approach and the sequence was verified as in-frame with the TUP-1 repressor domain.
b. Completed, 2002 . The yeast were transformed with these TRRAP fusion proteins, and analyzed by western blot for equal expression of prey fusion proteins using our recently derived TUP-l specific antibody. c. Completed, 2002 . It was established that the prey fusion proteins do not affect yeast viability in the presence or absence of 5-FOA. d. Completed, 2002 . The TRRAP fusion proteins were tested for their interaction with wildtype MycNTD bait proteins, include MbI and MBII deletion and point mutants as well as specificity controls for MycNTD interaction, including Gal4E2F, Gal4VP16, etc. e. Completed, 2004 . The region of TRRAP required for interaction with Myc was further refined using smaller fragments of TRRAP in the RTA (See Annual Report 2003) . This resulted in the identification of a 336 amino acid fragment of the 3830 amino acid TRRAP protein that was sufficient to interact with the MycNTD (Fig 1) . To further resolve the binding sites we employed smaller fragments of TRRAP and surveyed a panel of Myc NTD point mutants, but were unable to conclusively identify the key amino acid contact points. We then worked in collaboration with Dr. Cheryl Arrowsmith to express smaller fragments of the Myc-binding region of TRRAP in vitro to identify the smallest fragment that would interact with the MycNTD. This analysis showed that 160 amino acids of TRRAP are sufficient to interact with the smallest defined region of Myc essential for interaction (MBII) (Fig 1) . Further analysis by circular dichroism confirms the interaction of the 160 amino acids and the MycNTD MBII region. However, many different approaches and attempts to scale-up the production of the polypeptides for Nuclear Magnetic Resonance (NMR) analysis and identify the points of interaction between TRRAP/Myc, have been tested and exhausted but have not yielded the required reagents to conduct NMR. Thus, the smallest region identified as essential for MycNTD MBII interaction is the 160 amino acids of TRRAP (Fig 1) . f. Completed, 2004 . We have searched the sequence database for other polypeptides encoding this region and no hits were identified. This is not surprising given most interaction motifs are much smaller in size than 160 amino acids. Completed, 2004 . We focused in on one Myc interactor, GSK-3 alpha, that was cloned using the RTA as described. Ectopic expression of the tagged protein was analyzed for interaction (Fig 2 and Fig 3) and by immunofluorescence to determine subcellular localization relative to Myc (Fig 4) . j. Completed, 2004 . The Myc-binding protein, GSK-3 alpha, was tested for its ability to alter Myc function. Ectopic expression or RNAi knock-down of GSK-3 alpha had no effect on Myc autosuppression, apoptosis, growth, transformation. Pharmacological inhibitors to GSK-3 were also used to evaluate the effect of Myc's biological function, but no differences were evident. k. Completed, 2004 . The expression of Myc and the Myc-binding proteins was analyzed for expression and activity in cell lines and primary tissue samples derived from normal and transformed mammary carcinomas. GSK-3 is ubiquitously expressed. Key Research Accomplishments 9A region of TRRAP essential for interaction with Myc has been identified using the RTA and in vitro interaction analyses (Fig 1 & 5) . eTwo cDNA libraries have been constructed and screened to identify polypeptides that interact with the Myc N-terminus. Positive clones from the MCF-7 library have been isolated, rescreened and sequenced (Appendix A). *Further analysis of Myc:GSK-3 interaction was conducted (Fig 2-4) Reportable Outcomes "* Abstract presented at Reasons for Hope, Breast Cancer Conference, Orlando 2002 "* Ph.D. degree conferred based on project supported by this award "* Employment opportunities received based on training supported by this award "• Two manuscripts now in preparation will be credited to DOD funding.
Conclusions
As described in the first specific aim, the RTA was employed to identify a region of TRRAP which is required for binding to the Myc N-terminal domain. As outlined, partial fragments of TRRAP and Myc were tested by the RTA as well as in vitro interaction analyses to identify the minimal regions within each protein that are critical for interaction. We had hoped to map the precise points of TRRAP/Myc interaction using Nuclear Magnetic Resonance (NMR), but despite several attempts using a variety of strategies, soluble polypeptide at the levels required to conduct NMR were not achievable. While we have exploited the TRRAP:Myc interaction in this pilot project, we expect to extend this strategy to the other Myc interactions isolated in Task 2. The lead compounds generated by this work have the potential to be further developed into novel therapeutics that block Myc function as an oncogene. A manuscript describing these results is presently in preparation.
As outlined in the second specific aim, two cDNA libraries were constructed and screened using the RTA to identify novel Myc binding proteins. Positive clones resulting from the MCF-7 library screen were further characterized to ensure they were true Myc interactors and their identity was revealed through nucleotide sequencing. Further analysis of GSK-3/Myc was conducted and a manuscript describing the screen (Appendix A) as well as the further analysis of GSK-3/Myc is presently in preparation. With these interactors in hand the molecular mechanism of action of Myc in the carcinogenic process will be further revealed. In addition, these clones will provide the essential experimental tools to develop additional therapeutics that will break Myc interactions that hold a key role in the transformation. 
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(Transformation/transactivation domain-associated protein), was recently identified and found to interact with Myc at these conserved sites (McMahon et al., 1998; McMahon et al., 2000) . Thus, one critical function of the Myc NTD may be to recruit essential cellular factors required for Myc activity.
To gain a better understanding of Myc protein function at the molecular level, we sought to establish a high throughput screen to identify novel cofactors bound to Myc at the N-terminus. Currently, the identification, physical mapping and functional characterization of Myc NTD interactions has relied heavily upon labour intensive biochemical strategies. However, with the expanding interest and increased sense of urgency in the Myc field to understand Myc NTD function, a simpler and more high throughput method to examine Myc NTD interactions would be highly desirable. In the past, the investigation of Myc NTD-binding proteins has not generally involved yeast two-hybrid strategies due to the strong activation conferred by the Myc NTD when used as bait in these systems (Fields and Song, 1989) . In recent years, alternative two-hybrid approaches have become commercially available that can accommodate the use of selfactivating baits by moving the assay out of the nucleus and switching to reporter systems that do not use transcriptional activation as the method for interaction detection (Aronheim el al., 1997; Johnsson and Varshavsky, 1994) . Because Myc normally functions as a nuclear transcription factor, we reasoned that it would be most advantageous to allow the Myc NTD to function in its normal cellular setting and to employ a reporter system that would take advantage of Myc's inherent ability to activate.
To this end, a novel yeast two-hybrid screen termed the Repressed Transactivator Assay (RTA) was developed and we have now established its use with the Myc NTD as bait (Hirst et al, 2000) .
We demonstrate that the novel RTA system can be used to identify interactions at the Myc NTD in a sensitive and specific manner. We also performed a cDNA library screen using the Myc NTD as bait and show that binding events captured by RTA were also detected in vitro.
Materials and Methods

RTA constructs and Yeast strain:
The bait cDNAs were cloned into the pG yeast expression plasmid as fusions to the Gal4 DNA-binding domain (DBD, aa 1-147). Gal4-Myc NTD was constructed using and heat shock transcription factor 1 (HSF1, aa ) were also cloned by PCR using X/Y and X/Y ends respectively.
The control TUP1-fusion proteins were cloned into the yeast expression vector pBDH as fusions to the TUPI repression domain (RD, aa 1-200). Full-length human atubulin was cloned using X/Y digestion and ligation into pBDH. Mutagenesis to remove a TGA stop codon in the fusion region of TUPl-a-tubuln was performed using
Quikchange mutagenesis kit (Stratagene). Full length human TBP was PCR amplified with EcoRI and BamHI restriction site ends for cloning. Full length pRB-family inserts were used and cloned as follows: p107 was excised and cloned using X/Y, pRB excised and cloned using X/Y, p130 excised and cloned using X/Y from XXX. Full-length human GSK3ox was excised from XXX and cloned into pBDH at EcoRI. All fusion regions and open reading frames were sequence verified. PCR primer sequences used in the cloning of these constructs are be available upon request.
The Mavl08 reporter yeast strain has been previously described (Vidal et al., 1996) .
Solid and liquid yeast growth media:
Wildtype Mavl08 yeast cells were grown in complete yeast growth media in preparation for transformation. Single transformants were grown on -tryptophan (-trp) plates for propagation of Gal4-fusion bait vectors alone or -histadine (-his) plates for propagation of TUPl-fusion prey vectors alone. Cotransformants were grown ontryptophan-histadine-methionine (-trp-his-met) triple dropout plates. Where required Lmethionine was added to the -trp-his-met dropout media to a final concentration of 2mM (Sigma M-). 5-flouroorotic acid (FOA) was added directly to the media after sterilization to a final concentration of 0.05% (Toronto Research Chemical, F-). Liquid media was made in the same manner as solid plating media except that agar was omitted.
Lithium acetate (LiOAc) Yeast transformationr
Freshly prepared wildtype Mav108 cells were used in all transformation reactions.
Yeast cells in log-phase growth were harvested by centrifugation and aliquoted into lithium acetate mediated transformation reactions containing the appropriate combination of bait and prey plasmids. Reactions were incubated for 30 minutes prior to a 15 minute heat shocked at 42'C with an addition of 10% DMSO jist prior to heat shock. Each reaction was then plated onto the appropriate drop-out selection and resulting colonies incubated for 2-3 days at 30'C.
FOA plating and Liquid B3-galactosidase assays:
FOA selection platings were performed with freshly transformed Mavl08 cells.
Transformed yeast cells were picked, suspended in sterile ddH 2 0 and diluted to 1/10 and 1/100 with additional sterile ddH 2 0. All dilutions were performed in triplicate. A sample of each dilution (undiluted, 1/10 and 1/100) was then transferred by spotting onto +/-FOA plates and incubated at 30'C. Results were documented using Kodak gel doc system.
Liquid j3-galactosidase assays were also performed using freshly transformed cells that were grown ovemight in liquid culture. Cells were pelleted, lysed and subject to 7 standard analysis of 13-galactosidase activity using ONPG substrate. All samples were tested in triplicate.
Immunoblot analysis:
Yeast protein lysates were made using SDS/urea buffer and electrophoretically separated on a 12% polyacrylamide gel. Specific bands corresponding to the TUP1-fusion proteins were detected using a monoclonal a TUP1 antibody at 1:1000 concentration in 5% skim milk + 0.1% Tween20 solution. Bands were visualized using standard chemiluminscence reagents according to manufacturers' protocol (Pierce).
MCF-7 cDNA Library Synthesis and Screening:
MCF-7 cDNA library synthesis has been described elsewhere (Hirst et al, 2000) .
A survey of 30 random library clones revealed a ligation efficiency of greater than 90%/o with an average cDNA insert size of 1.5kb. A total number of 1.6 x 106 primary library transformants was obtained.
The Gal4-Myc NTD bait and MCF-7 cDNA library vectors were serially transformed into Mavl08 cells. Transformation reactions were plated directly onto -trphis-met +FOA screening plates. A total of XXX cDNAs were screened. Surviving colonies were transferred to -trp-his-met master plates for passage and storage. Master plate clones were then tested on +/-FOA,+/-Met selection plates for specificity of growth.
Subsequent screening by replating and activator bait panel tests was performed using extracted library plasmids that were retransformed into fresh Mavl08 cells.
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Extraction of Library plasmid and seguence analysis:
YPER reagent (Pierce). Electroporation into homemade cells.
In vitro expression, binding and competition experiments:
Library cDNA inserts were PCR amplified to include a T7 promoter sequence performed using the same conditions as binding reactions except that purified GST-free
Myc NTD was titrated into the competition reactions in the indicated amounts. Reactions proceeded and were processed as described above.
Results
Outline of the basic components of the Myc RTA assay and reporter gene system Schematic outline of the basic components of the RTA system are detailed in DNA-binding domain (DBD) to be used as bait (Gal4-Myc NTD). In contrast to other two-hybrid strategies, the RTA requires strong activation of the reporter system by the Gal4-fusion bait as interactions are detected by the suppression, rather than activation, of reporter gene expression. This is achieved by fusing prey proteins to the repression domain (RD) of TUP1, a general yeast repressor protein, so that upon interaction of the Gal4-Myc NTD bait with a TUPl-fusion prey, expression from the reporter will be inhibited. We established the RTA using the Mavl08 yeast cell strain, which contains both ura3 and lacZ reporter genes (Vidal et al, 1996) . Activation of the ura3 reporter Control interactions for Gal4-Myc NTD and Gal4-E1A baits were detected by RTA using both reporters An important pre-requisite for the RTA system is the ability of the bait fusion to confer adequate reporter gene activation. Mavl08 yeast cells were transformed with empty pG bait vector, Gal4-Myc NTD or Gal4-ElA alone. Plating onto +FOA clearly revealed that control cells transformed with pG, which has no activation potential, were able grow on +/-FOA conditions to a similar extent (Figure 2A ). By contrast, yeast cells expressing either Gal4-Myc NTD or Gal4-ElA were unable to grow on +FOA due to ura3 reporter gene expression. This lack of viability was not due to the transformation procedure or to a general toxicity of the expressed bait since both Gal4-Myc NTD and Gal4-ElA transformants were able to grow on control -FOA media. It was important to observe that cells transformed with the TUP1-fusion preys alone were able to grow to a similar extent on either + or -FOA conditions, indicating that the proteins were not toxic to yeast cell growth nor could they activate ura3 gene expression on their own ( Figure   2B ). The Gal4-baits were then cotransformed with a control panel of TUP1-fusion prey proteins and when plated onto +FOA. Only those cells harbouring an interacting pair were able to grow ( Figure 2C ). Again, cells plated onto control FOA-free media were fully viable indicating that the observed lack of growth on +FOA was not due to a general lack of viability (data not shown). Positive control TUP1-fusion preys were cloned from full-length templates of known Myc NTD-interacting proteins, including ax- et al., 1995) , TATA-binding protein (TBP) (Hateboer et al., 1993; Maheswaran et al., 1994; McEwan et al., 1996) and p107 (Beijersbergen et al., 1994; Gu et al., 1994) , which conferred significant rescue of growth when coexpressed with the Gal4-Myc NTD bait ( Figure 2C , upper panel). In contrast, non-interacting negative control Myc NTD TUP1-fusions, pRB, p130 and pBDH empty prey vector, were unable to rescue yeast cell growth on +FOA. When this panel of positive and negative Myc NTD interactors was then coexpressed with the Gal4-ElA bait, a different pattern of growth was detected on +FOA ( Figure 2C , lower panel). Because E1A encodes many of the same biological activities of Myc and because it is has well-established interaction with TBP (Molloy et al., 1999) and the pRB-family of proteins, it was used as a specificity control in the experiment. As expected, Gal4-EIA expressing cells were strongly rescued by coexpression of TBP and the pRB-family proteins, p107, pRB and p130. Under these experimental conditions no significant growth was detected for cotransformants of Gal4-E1A and either ax-tubulin or the pBDH negative control suggesting that these proteins do not interact.
Quantitation of lacZ reporter gene activity by liquid P3-galactosidase assay in
Gal4-Myc NTD cotransformants revealed a pattern of lacZ reporter gene activity that supported the ura3 reporter observations on +FOA and correlated with the presence of positive and negative TUPI-fusion prey interactions. All 13-galactosidase assays were performed in triplicate and a representative data set is shown in Figure 2D . Positive control TUPI-fusion preys, oc-tubulin, TBP and p107, had significantly lower relative 13-gal units as compared to the pBDH vector control or to pRB and p130 negative controls, which was indicative of interaction. Importantly, concordance between the ura3 and lacZ reporters showed that the RTA system was able to differentiate between positive and negative Myc NTD interactions using reporters that have distinct promoter configurations indicating that the positive interactions detected were not promoter-context dependent.
Although appropriate TUPl-fusion prey protein expression can be inferred from the results shown in Figures 2C and 2D , immunoblot analysis was performed to ensure that each prey could be detected and at the expected migration. Furthermore, this would clarify that the failure to detect an interaction was not due to lack of fusion protein expression The TUP1-fusions were expressed, as detected by a oxTUPI monoclonal, and migrated to the correct predicted molecular size ( Figure 2E , specific TUP1-fusion bands marked by an arrow). Some variability in the abundance of the different fusion proteins was observed, however, all non-interacting control TUP1-fusions, pRB, p130 and pBDH were clearly detected excluding the possibility that negative results generated by these preys was due to lack of protein expression.
Rescue of growth on +FOA is dependent on the concurrent expression of the interacting TUPl-fusion
To determine if the growth rescue by the positive controls would still be maintained on +FOA in the absence of an interacting prey, TUP1-fusion protein expression was selectively eliminated. TUPl-fusion prey expression is controlled from a regulatable yeast Met3p promoter that can be repressed in the presence methionine (+Met), allowing for the inhibition of prey protein production by a simple change in growth conditions. Mavl08 yeast cells were cotransformed as before with the Gal4-Myc NTD and control TUP1-fusion preys, except that each reaction was equally divided and plated onto +Met and -Met growth conditions. Colonies of equal number and size were observed between the + and -Met growth conditions indicating that the high methionine environment had no detrimental effect on either transformation efficiency or yeast cell growth (data not shown).
The resulting -Met and +Met cotransformants were plated in parallel and concurrently onto all four selection conditions denoted -FOA, +FOA, -FOA+Met and +FOA+Met. If the observed growth on +FOA is specific to the concurrent expression of an interacting prey then plating onto +FOA+Met conditions would lead to the loss of rescue when expression of the interacting TUP1-fusion is suppressed. A representative experiment is shown in Figure 3A . Both -Met and +Met cotransformants were able to grow on control FOA-free media in the presence or absence of additional methionine, indicating that these cells were fully viable ( Figure 3A , see -FOA and -FOA+Met panels). Plating onto +FOA media showed that both TBP and p107 TUP1-fusion preys were efficient at rescuing yeast cell growth of either -Met or +Met grown 14 cotransformants. Importantly, comparable levels of +FOA rescue were achieved from both -Met and +Met grown colonies, which indicated that the suppression of prey expression under +Met was efficiently reversed when the cells were shifted back to methionine-free growth conditions. More importantly, when the cells were plated onto +FOA+Met media, no significant rescue of yeast cell growth could be detected. This indicated that the observed growth on the matching +FOA plate was indeed dependent on the expression of the interacting TUP1-fusion prey ( Figure 3A , see +FOA+Met panels). Each Gal4-Myc NTD mutant bait was first tested to ensure that an adequate level of reporter gene activation would be achieved. Deletion of MB1 and MB2 or substitution at W135E did not result in detectable defects in ura3 activation and the Myc mutants were as efficient as wildtype at killing the cells on +FOA ( Figure 4A ).
Coexpression of the wildtype Gal4-Myc NTD with either TBP or p107 TUPIfusion preys again resulted in significant growth on +FOA when compared to the negative pBDH empty vector control ( Figure 4B ). The mutant Myc NTD baits were then tested for interaction with TBP and no significant changes in the level of growth rescue were observed on +FOA for AMB1, AMB2 or W135E. Liquid 13-galactosidase analysis of the deletion mutant baits with TBP showed that both mutant baits produced similar relative P-gal units as compared to wildtype Gal4-Myc NTD, which were as a group significantly different from the pBDH vector control ( Figure 4C ). This suggested that loss of either MB1 or MB2 did not significantly alter interaction of the Myc NTD with TBP. However, when the mutant Myc baits were coexpressed with p107, a qualitative decrease in yeast cell growth was reproducibly observed for AMB1 cotransformed cells on +FOA selection. This loss of yeast cell viability on +FOA with p107 was not observed to any significant extent with either AMB2 or W135E mutant baits. Liquid 03-galactosidase experiments supported those results on +FOA and revealed that cells cotransformed with Gal4-AMB1 and p107 did have a significant elevation of f3-gal units above that of the AMB2 mutant bait or the wildtype Gal4-Myc NTD control ( Figure 4C ).
Further experiments are required to fully understand the significance of this observation, however, this data suggests that MB1 may be an important region of interaction between the Myc NTD and p107.
Identification of novel Myc NTD interacting proteins by library screen using RTA To identify novel Myc NTD-interacting proteins, the Myc RTA system was used to screen a human cDNA library, which was derived from a MCF-7 transformed breast carcinoma cell line and constructed specifically for use in the RTA. The Gal4-Myc NTD bait and MCF-7 TUPI-fusion library were serially introduced into the Mavl08 yeast cells and approximately 1.5x 106 transformants were plated directly onto +FOA screening plates. Library clones that were able to grow on +FOA during the screening period were transferred to FOA-free master plates for continued passage and storage. The library clones were then assessed for their ability to again grow on +FOA and to determine whether this growth was dependent on the concurrent coexpression of the library fusion by observing their phenotype on +Met media. This involved transferring of library clones from the master plate to a series of selection plates containing +/-FOA and +/-Met media conditions. A representative set of selection plates are shown in Figure 5A .
The response of library clones to the various media conditions was closely monitored and four pattern of growth were clearly distinguished ( Figure 5B ). Group 1 clones were viable when picked from screening plates onto master plates, but did not grow when transferred onto selection plates. Group 2 clones were able to grow on selection plates, but did not confer any significant rescue of growth when plated onto +FOA media. Library clones from groups 1 and 2 were not carried any further. Group 3 clones displayed impressive growth on +FOA, but could also grow on +FOA+Met media, which suggested that the growth rescue could be non-specific. Group 4 clones exhibited the ideal pattern of selection showing strong growth rescue on +FOA and specific loss of this rescue when transferred to +FOA+Met media. These clones were brought forward into the next screen.
Retransformation test of selected library clones and TUP..-fusion protein analysis
Library vectors from group 4 clones were extracted and purified. In conjunction with sequence data, those clones determined to translate in-frame fusion proteins were tested. The data for a panel of select library clones, which represents the spectrum of results generated, is shown.
To determine if the expression of the library preys was toxic to yeast growth, on +FOA and were discarded (data not shown). Most library proteins were able to rescue growth on +FOA after retransformation and a representative selection of data is shown in Figure 6B . As seen previously, all cells were able to grow to a similar extent on control FOA-free media +/-Met. However, a distinct loss of yeast growth was observed on +FOA+Met media, which indicated specificity of growth rescue to the concurrent expression of the library protein ( Figure 6B ).
Imnmunoblot analysis under +/-Met conditions established that efficient inhibition of library prey expression had indeed occurred ( Figure 6C , compare between -and + lanes, specific bands are marked by an arrow). More importantly, proper expression of the TUPI-fusion library proteins was confirmed by detection of a specific band at the expected migration.
Activator panel test of library clones for interaction with Myc-specific and nonspecific baits
To further examine the specificity of the library proteins for interaction with the Gal4-Myc NTD prey, those clones harbouring in-frame TUPl-fusions were then coexpressed with a panel of Myc NTD-related and unrelated activator baits. Related
Gal4-activator baits included c-Myc-family proteins, N-Myc and L-Myc, which were constructed using wildtype sequence that was directly homologous to the amino acids 1-262 of c-Myc. Mutant Myc NTD baits included those previously used in Figure 4 .
Unrelated activator baits included full length ElA, used previously as a specificity control (Figure 2) , and the activation domains of VP16 and HSF1.
This experiment was successful in identifying the library clones with differential ability to interact with the various activator baits. For comparison, TBP and pBDH expressing control cotransformants were also tested. As seen previously, TBP was able to confer robust growth when coexpressed with WMyc NTD wildtype or mutant proteins, as well as with full length E1A (Figure 7) . Importantly, no growth was detected for any of the pBDH cotransformants indicating that the TUP1 portion of the fusion did not contribute to interaction (Figure 7 , bottom panel).
When the library proteins were tested, clones such as 2-20-1 and 6-11-1 appeared to confer a similar level of growth rescue across all baits suggesting non-specific association with activation domains. Although clone 6-11-1 did not confer rescue of the W135E mutant bait, suggesting disruption to the wildtype Myc NTD sequence had an effect on interaction. In general, the library clones appeared to achieve the strongest growth when coexpressed with the Myc NTD and relatively little growth with the other related or unrelated activator baits (Figure 7 , see clones 2-9-1, 11-26-1 and 9-11-1). This suggested that the observed response was specific to the c-Myc NTD. Cotransformation with the Myc NTD mutant baits gave rise to the most intriguing data, revealing that specific mutations could abrogate growth rescue by particular library preys and indicating regions of the Myc NTD that were potentially important for these interactions. A number of library preys had growth profiles similar to clone 9-11-1 where no significant grow was observed for any of the related, unrelated or mutant Myc NTD baits, suggesting that interaction was dependent on the wildtype Myc sequence.
In vitro expression, binding and specificity of wildtype GST-Myc NTD and mutant
GST-AMB1 and GST-AMB2 fusions for 35 S-methionine labeled library proteins
To assess the ability of these proteins to bind the Myc NTD in vitro, each library clone was translated by a reticulocyte lysate system using radiolabeled 35S-methionine from a T7 promoter-tagged PCR template of the cloned cDNA. A sample of each reaction was electrophoretically separated and translated products were detected by autoradiography. The most abundant product of each translation reaction migrated to the appropriate size corresponding to the specific library template released by SalI restriction enzyme digestion (Figures 8A, lkb size marker indicated by an arrow and Figure 8B , specific translation products marked by an arrow). TBP and full length Max were also translated, to serve as positive and negative controls for Myc NTD binding, respectively.
Myc NTD wildtype and deletion mutant proteins were cloned in-frame with GST and expressed recombinantly. Crude lysates for each GST-fusion and GST alone were prepared and a sample of each was electrophoretically separated to determine their relative abundance. The GST proteins were the most abundant species of each respective sample and were expressed to approximately equivalent levels ( Figure 8C , GST-fusion protein band marked by an arrow). The binding reactions were performed using unpurified crude lysates of the GST proteins since it was reasoned that the increase in reaction complexity conferred by the presence endogenous bacterial proteins would ameliorate background-binding events and enhance the specificity of the in vitro conditions.
To ensure that 35 S-labeled protein products were not binding to the glutathionine sepharose beads on their own, a preclear reaction for each sample was performed. This appeared to be relatively resistant to competition. Taken together, the results shown in Figure 8D and 8E indicated that specific binding between the Myc NTD and library proteins could be detected in vitro.
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The library 35 S-labeled proteins were then incubated with MB1 and MB2 deletion mutant GST-fusion proteins, GST-AMB1 and GST-AMB2, to test for dependence of these interactions on the presence of these sequences ( Figure 8F ). Initial inspection of the results found that, under these conditions, neither deletion mutant exhibited complete loss of binding to any of the three library proteins tested. However, when compared to the wildtype GST-Myc NTD, some subtle differences could be observed in relative amount of radioactivity precipitated by each Myc Box mutant. For example, clone 6-11-1 appeared to be less efficiently bound by GST-AMB1 and GST-AMB2 thus resulting in lighter bands as compared to that precipitated by wildtype GST-Myc NTD. By comparison, clone 9-11-1 appeared to be as efficiently bound by GST-Myc NTD wildtype or mutant proteins resulting in similar band intensities across the reactions.
Binding of clone 11-26-1 to the GST-fusions resulted in three distinct levels of band intensities with the GST-AMB2 mutant displaying the greatest deficit in binding as compared to wildtype.
Myc NTD and full length GSK3A interact in RTA and in vivo
Of the proteins identified to interact with the Myc NTD by our library screen, one clone in particular was of immediate interest to us. Clone 9-11-1 was found to encode the kinase domain of the GSK3ax protein that has been implicated to phosphorylate Myc at the NTD in vivo (Lutterbach and Hann, 1994; Pulverer et al., 1994) . Full-length human GSK3ct was cloned in-frame with TUPI to determine if it would be dle to interact with the activator bait panel in a similar manner to clone 9-11-1, which encodes only the kinase domain. Coexpression of full length GSK3oL with the wildtype Gal4-Myc NTD bait revealed that it rescued growth to a similar extent as clone 9-11-1. Similar to clone 9-11-1, full-length GSK3(x conferred growth with coexpressed with oMyc and not with NMyc or L-Myc NTD baits. However, full length GSK3cc had slight growth with AMB2 mutant and the unrelated VP16 bait where as clone 9-11-1 did not. Interestingly, the AMBI bait, which is deleted for GSK3a phosphorylation site, had no growth on +FOA.
Overall, these results show that the isolated kinase domain and the full-length GSK3Cz proteins behave in a comparable manner, indicating that the RTA system was able to appropriately identify interaction domains. Moreover, the RTA implicates the Myc MB1 sequenced and the kinase domain of GSK3(x as the important determinants of interaction between these two proteins.
Discussion
We have now established a high throughput screen for identifying novel Myc NTD-interacting proteins. We demonstrate that the novel RTA system was able to correctly differentiate between positive (oa-tubulin, TBP and p107) and negative (pRB, p130 and pBDH empty vector) TUP1-fusion prey control interactions at the Myc NTD in a sensitive and specific manner. By determining the optimal parameters of specificity and sensitivity using a panel of known Myc-NTD binding proteins, then allowed us to more clearly interpret data generated by novel proteins isolated through screening of a cDNA library specially constructed for use in the RTA. A. Group 1 clones were viable when picked from original screening pates onto master plates, but were not viable when transferred from master plates to selection plates. Group 2 clones were viable on selection plates, but did not confer growth on FOA. Group 1 and 2 clones were not carried further. Group 3 clones were able to confer strong rescue on FOA, however, strong growth was also seen on +Met, suggesting that the growth on FOA could be non-specific. Group 4 clones exhibit the ideal selection criteria, rescue of growth on FOA and loss of this rescue when transferred to +Met indicating specificity of growth on FOA to the concurrent expression of the library TUPl -fusion.
Library clones alone 
